title: Point-of-care and standard laboratory coagulation testing during cardiovascular surgery: balancing reliability and timeliness.
abstract: OBJECTIVE
  The use of point-of-care technology has increased faster than efforts to validate its effectiveness compared to standard laboratory testing modalities. To address this issue with a current point-of-care coagulation system (HEMOCHRON Jr, International Technidyne Corporation (ITC), Edison, NJ), we designed a study to test the hypothesis that data obtained from point-of-care coagulation equipment correlates with data obtained from standard laboratory coagulation equipment. One of the potential advantages gained using point-of-care testing is the ability to obtain more rapid results. To address this issue, turnaround time, defined as the elapsed time (in minutes) from when the sample was acquired from the patient until the investigators knew the results, was also determined.
  
  
  METHODS
  Following Human Investigation Committee approval and informed consent, a prospective study was conducted to compare results obtained from point-of-care coagulation equipment with those results obtained from standard laboratory coagulation equipment. The study was performed in three groups of patients undergoing cardiovascular surgery, each requiring different levels of anticoagulation.
  
  
  RESULTS
  Of the 83 patients who met the inclusion criteria, the correlation (combining data from groups 1-3) between results obtained from point-of-care and standard laboratory prothrombin time was r = 0.867, p < 0.001. The correlation (group 3) between point-of-care and standard laboratory international normalized ratio was r = 0.943, p < 0.001. The correlation (combining data from groups 1 & 2) between point-of-care and standard laboratory activated partial thromboplastin time was r = 0.825, p < 0.001. Median turnaround time for the standard laboratory was 90 minutes, with a mean turnaround time of 74 to 78 minutes, depending upon the group. In contrast, the median turnaround time for point-of-care testing was two minutes and 14 seconds.
  
  
  CONCLUSIONS
  The results from this study population reveal that data obtained from point-of-care prothrombin time, international normalized ratio and activated partial thromboplastin time results correlate with results obtained from standard laboratory coagulation testing. The value of obtaining reliable results in a timely fashion offers a potential advantage for point-of-care testing in dinical situations, such as in the operating room, where saving time may translate into financial savings.
authors.affiliation: Department of Anesthesiology, Yale University School of Medicine, Ridgefield, CT, USA. jfitch@bcm.tmc.edu
authors.forename: J C
authors.initials: JC
authors.lastname: Fitch
authors.forename: G P
authors.initials: GP
authors.lastname: Mirto
authors.forename: K L
authors.initials: KL
authors.lastname: Geary
authors.forename: D W
authors.initials: DW
authors.lastname: Byrne
authors.forename: R L
authors.initials: RL
authors.lastname: Hines
mesh_terms: D000368:Aged; D001780:Blood Coagulation Tests / Q000295:instrumentation; D002315:Cardiopulmonary Bypass; D016022:Case-Control Studies; D005260:Female; D006331:Heart Diseases / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000601:surgery; D019095:Point-of-Care Systems; D011446:Prospective Studies; D013997:Time Factors